Thursday, August 06, 2020 11:19:36 PM
RLFTF"s frontman has a medical "pedigree".
The trials are being done in conjunction with NeuroRx, whose principal's bio is below, what an impressive background.
Chief Executive Officer Jonathan C. Javitt, M.D., M.P.H.
Dr. Javitt has played leadership roles in seven successful healthcare IT and biopharma startups with public exits. He has additionally led drug-development engagements for Merck, Allergan, Pharmacia, Novartis, and Pfizer. He was appointed to healthcare leadership roles under Presidents Reagan, George H.W. Bush, Clinton, and George W. Bush. In the latter role he was commissioned to lead the White House policy for universal adoption of Health IT and establishment of the Office of the National Coordinator. He is a graduate of Princeton University, Cornell University Medical College, Harvard School of Public Health, the Wills Eye Hospital, and Johns Hopkins Medical School . Dr. Javitt has published more than 200 scientific works in the areas of health outcomes and pharmacoeconomics that have been cited by more than 16,000 people.
And have you listened to him -
https://www.youtube.com/watch?v=lgmpS2N8124
Meanwhile BPSR has -
EXECUTIVE LEADERSHIP
Albert Mitrani
CEO & Co-Founder
Board Member
Dr. Maria Ines Mitrani, M.D., PhD
CSO & Co-Founder
Board Member
George Shapiro, M.D., FACC
Chief Medical Officer
Board Member
Ian T. Bothwell
Chief Financial Officer
Board Member
SCIENCE & REGULATORY ADVISORY BOARD
Michael A. Bellio, Ph.D.
Vice President, Manufacturing & Processing
Ivan Santos
Research & Development Scientist
Julian Milberg
Process Engineer
Zanub Abdullah
Cell Processing Specialist
MEDICAL ADVISORY BOARD
Allen J. Meglin, M.D.
Medical Director, Board Member
Bryan Kelly, M.D.
Medical Advisor
Carolyn DeLucia, M.D.
Medical Advisor
Paul Thompson, M.D.
Medical Advisor
Marianne LaBarbera, M.D.
Medical Advisor
Paul Francis Campion, M.D.
Medical Advisor
Sonita Sadio, M.D.
Medical Advisor
Henry C. Sobo, M.D.
Medical Advisor
Rolf Wallin, M.D.
Medical Advisor
Dr. Robert Madda, M.D.
Medical Advisor
Raymond Ishman, M.D.
Medical Advisor
William K. Kapp III, M.D., M.S., FAAOS
Medical Advisor
Stephanie M. Singer, D.O.
Medical Advisor
Dr. Julian Gershon, D.O.
Medical Advisor
Rebecca Murray, F.N.P.
Medical Advisor
Juan Chavez, M.D.
Medical Advisor
Fernando Pinto, M.D.
Medical Advisor
Michale J. Barber, M.D.
Medical Advisor
Alvaro J. Ocampo, M.D. MPH
Medical Advisor
David C. Socol, M.D.
Medical Advisor
John R. Baird, M.D.
Medical Advisor
Ken Sharlin, M.D., M.P.H., IFMCP
Medical Advisor
Randolph Whipps, M.D., F. A.C.C.
Medical Advisor
Riley J. Williams III, M.D.
Medical Advisor
Barry Kuttner, M.D., PhD
Medical Advisor
Mounir Wassef, D.O., FAOCD, FAAD
Medical Advisor
Robert Neal Rouzier, M.D.
Medical Advisor
Bennett L. Willard, D.O.
Medical Advisor
Dan Sperling, M.D., D.A.B.R.
Medical Advisor
Glenn Charles, D.O.
Medical Advisor
Eugene Rajaratnam, M.D., F.A.C.S.
Medical Advisor
Matthew Lief, M.D., F.A.C.S.
Medical Advisor
Josh Sandell, D.C., D.A.C.B.S.P., A.T.C., C.S.C.S., I.C.S.S.D.
Medical Advisor
Billy Ray Ledbetter, M.D.
Medical Advisor
Mohammed Siddiqui, M.D.
Medical Advisor
Matthew Burnett, D.C., C.C.S.M.S, C.F.S.S.
Medical Advisor
FINANCIAL & REGULATORY
ADVISORY BOARD
Larry Ziff
Financial and Regulatory Advisor
STRATEGIC ADVISORS
Raymond Zoeller
Strategic Advisor
Humanigen, HGEN is here -
https://www.humanigen.com/about-humanigen
saving nickels saving dimes
working till the sun don't shine
looking forward to happier times
1963, Roy Orbison - On Blue Bayou
Recent CYDY News
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/09/2024 02:30:20 AM
- Form 424B3 - Prospectus [Rule 424(b)(3)] • Edgar (US Regulatory) • 03/01/2024 10:16:47 PM
- Form 424B3 - Prospectus [Rule 424(b)(3)] • Edgar (US Regulatory) • 03/01/2024 10:15:34 PM
- Form 424B3 - Prospectus [Rule 424(b)(3)] • Edgar (US Regulatory) • 02/22/2024 10:16:11 PM
- Form EFFECT - Notice of Effectiveness • Edgar (US Regulatory) • 02/22/2024 05:15:08 AM
- Form 3 - Initial statement of beneficial ownership of securities • Edgar (US Regulatory) • 02/16/2024 02:00:24 AM
- Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] • Edgar (US Regulatory) • 02/12/2024 10:31:57 PM
- Form 424B3 - Prospectus [Rule 424(b)(3)] • Edgar (US Regulatory) • 01/29/2024 10:22:17 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/29/2024 01:40:14 PM
- Form 424B3 - Prospectus [Rule 424(b)(3)] • Edgar (US Regulatory) • 01/19/2024 10:15:35 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 01/16/2024 10:16:04 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/06/2024 02:04:57 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/06/2024 02:04:20 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/06/2024 02:02:59 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/06/2024 02:02:30 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/06/2024 02:01:55 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/06/2024 02:01:14 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 12/22/2023 10:15:19 PM
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM